Abstract
The clinical performance of the Copper T380A (TCu380A) and the Multiload 250 (MLCu250) intrauterine devices (IUDs) were evaluated for 12 months in a group of women who had one of the two IUDs inserted. Results are from a randomized clinical trial conducted at four collaborating research sites located in three developing countries.
The gross cumulative life-table pregnancy rate of the TCu380A IUD was significantly lower than the rate with the MLCu250 IUD at 12 months (0.5 and 1.2, respectively,p<0.01). No statistically significant differences between the two study IUDs were found with regard to IUD expulsion or IUD removal due to bleeding/pain, personal reasons, medical reasons, or planned pregnancy. TCu380A IUD users were more likely to report experiencing increased dysmenorrhea (p<0.01) or intermenstrual pelvic pain (p<0.01) than were MLCu250 IUD users. However, few of these users discontinued use of their assigned IUD because of having experienced menstrual bleeding disturbances or intermenstrual pelvic pain.
These data indicate that the TCu380A IUD may be a better option than the MLCu250 IUD for women wishing to practice highly effective long-term birth control without having to resort to hormonal methods.
Resumé
Les résultats cliniques des dispositifs intra-utériens (DIU) Copper T38OA (TCu380A) et Multiload 250 (MLCu250) ont été évalués pendant 12 mois chez un groupe de femmes qui portaient l'un ou l'autre de ces dispositifs. Les résultats proviennent d'un essai clinique randomisé, effectué en collaboration par quatre établissements de recherche dans trois pays en développement.
Au terme de 12 mois, le taux brut cumulé de grossesses des tables de survie pour le dispositif TCu380A était significativement inférieur au taux correspondant pour le dispositif MLCu250 (0,5 et 1,2 respectivement,p<0,01). Aucune différence statistiquement significative entre les deux dispositifs étudiés n'a été constatée du point de vue de l'expulsion du DIU ou de son retrait pour cause de microrragie/douleurs, pour des raisons personnelles ou médicales ou pour une grossesse planifiée. Les utilisatrices du TCu380A ont plus fréquemment signalé une dysménorrhée (p<0,01) ou des douleurs pelviennes intermenstruelles (p<0,01) que les utilisatrices du MLCu250. Peu nombreuses était cependant cells qui avaient, en raison de perturbations du flux menstruel ou de douleurs pelviennes intermenstruelles, abandonné l'usage du dispositif qui leur avait été assigné.
Ces résultats indiquent que le dispositif TCu380A représente peut-être une meilleure solution que le dispositif MLCu250 pour les femmes recherchant à long terme une méthode hautement efficace de régulation des naissances, sans avoir recours aux méthodes hormonales.
Resumen
El resultado clínico de los dispositivos intrauterinos (DIU) Copper T380A y Multiload 250 (MLCu250) se evaluó durante 12 meses en un grupo de mujeres a quienes se había colocado uno de los dos DIU. Los resultados corresponden a un ensayo clínico aleatorizado efectuado en cuatro emplazamientos de investigaciones en colaboración situados en tres países en desarrollo.
La tasa bruta acumulativa de embarazo de las tablas de vida del DIU TCu380A fue significativamente inferior a la tasa correspondiente al DIU MLCu250 a los 12 meses (0,5 y 1,2, respectivamente,p<0,01)). No hubo diferencias estadísticamente significativas entre los dos DIU del estudio con respecto a su expulsión o retiro debido a microrragia/dolor, razones personales, razones médicas o embarazo planificado. Era más probable que las usuarias del DIU TCu380A notificaran mayor dismenorrea (p<0,01) o dolor pélvico intermenstrual (p<0,01) que las usuarias del DIU MLCu250. Sin embargo, un número menor de este grupo de usuarias dejó de utilizar el DIU que le había sido asignado por haber experimentado trastornos menstruales de microrragia o dolor pélvico intermenstrual.
Estos datos indican que el DIU TCu380A podría ser una mejor opción que el DIU MLCu250 para las mujeres que desean praticar un control de la natalidad a largo plaza altamente eficaz sin tener que recurrir a métodos hormonales.
Similar content being viewed by others
References
Sivin I, Greenslade F, Schmidt F, Waldman SN. The copper T380 intrauterine device: a summary of scientific data. New York: The Population Council, 1993.
Mauldin WP, Segal SJ. IUD use throughout the world: past, present and future. A new look at IUDs-advancing contraceptive choices. New York, March 27–28, 1992.
Tatum H, Connell-Tatum EB, Waldman SN, Greenslade FC, The new ParaGard Copper T380A intrauterine device. Med Digest. 1989;9:1–5.
Diaz J, Pinto Neto A, Diaz M, Marchi NM, Bahamondes L. Long-term evaluation of the clinical performance of the TCu200B and the TCu380A in Campinas, Brazil. Adv. Contracept. 1992;8:67–72.
Sung S, Lian LJ, Liu X. Comparative clinical experience with three IUDs, TCu380Ag, TCu200C and Mahua ring in Tianjin, People's Republic of China. Contraception. 1984;29:229–39.
Diaz J, Diaz MM, Pastene R, Araki A, Faundes A. Randomized clinical study of the TCu380A and the Lippes Loop C, in Campinas, Brazil. Contraception. 1982;26:221–8.
Sastrawinata S, Farr G, Prihadi H, Hutapea M, Anwar I, Wahyudi, Sunjoto KP, Champion CB, Robbins M. A comparative clinical trial of the TCu380A, Lippes Loop and Multiload Cu375 IUDs in Indonesia. Contraception. 1991;44:141–54.
Sivin I, Schmidt F. Effectiveness of IUDs: a review. Contraception. 1987;36:55–84.
Sivin I, Tatum H. Four years of experience with the TCu380A intrauterine contraceptive device. Fertil Steril. 1981;36:159–63.
World Health Organization. The TCu380A, TCu220C, Multiload 250 and Nova-T IUDs at 3,5, and 7 years of use: results from three randomized multicentre trials. Contraception. 1990;42:141–58.
Chi I-c. The Multiload IUD-a U.S. researcher's evaluation of European device. Contraception. 1992;46:407–25.
Cox DR. Regression models and life tables. J Roy Stat Soc. 1972;34:184–220.
Breslow NE, Day NE. The analysis of case-control studies. Statistical methods in cancer research, vol. 1. Lyons, France: International Agency for Research on Cancer, 1980.
Tietze C, Lewit S. Recommended procedures for the statistical evaluation of intrauterine contraception. Stud Fam Plann. 1973;4:35–41.
Kalbleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
Ladipo OA, Farr G, Otolorin E et al. Prevention of IUD-related pelvic infection: the efficacy of prophylactic doxycycline at IUD insertion. Adv Contracept. 1991;7:43–54.
Tsalikis T, Stamatopoulos P, Kalachanis J, Mantalenakis S. Experience with the MLCu250 IUD. Adv Contracept. 1986;2:393–7.
Fylling P. Clinical performance of Copper-T 200, Multiload 250 and Nova T: a comparative multicentre study. Contraception. 1987;35:439–46.
McCarthy T, Ramanchandran L, Ratnam SS. Interim 4-year results of a comparative study between the Nova T and the Multiload 250. Adv Contracept. 1987;3:323–6.
Soeprono R. Extended use of the Multiload Cu250. Adv Contracept. 1988;4:109–13.
Rhemrev PER, Van Os WAA, Edelman DA, Badrawi HH. Medical removals of the Multiload IUD. Adv Contracept. 1988;4:125–30.
Batar I. MLCu250 IUD: a decade of experience. Adv Contracept. 1988;4:271–9.
Batar I. Clinical experiences with MLCu250 and MLCu375 IUD. Adv Contracept. 1992;8:73–80.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farr, G., Amatya, R. Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries. Adv Contracept 10, 137–149 (1994). https://doi.org/10.1007/BF01978107
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01978107